Related Experiment Videos
Valproic acid hepatotoxicity in human liver slices
R Fisher1, H Nau, A J Gandolfi
1Department of Pharmacology, University of Arizona, Tucson.
Drug and Chemical Toxicology
|January 1, 1991
Summary
Valproic acid (VPA) causes liver damage in some human liver slices. This study identified varying sensitivity to VPA-induced hepatotoxicity in vitro, with no current correlation to donor age or sex.
Area of Science:
- Hepatotoxicity research
- Drug-induced liver injury
- In vitro toxicology
Background:
- Valproic acid (VPA) is an anticonvulsant and mood-stabilizing drug.
- Hepatotoxicity is a known, albeit rare, adverse effect of VPA therapy.
- Individual susceptibility to drug-induced liver injury varies significantly.
Purpose of the Study:
- To investigate differential sensitivity of human liver slices to VPA-induced hepatotoxicity.
- To establish an in vitro model for assessing VPA hepatotoxicity.
- To identify factors influencing VPA-induced liver injury.
Main Methods:
- Human liver slices were cultured in organ culture.
- Incubation with valproic acid (VPA) at therapeutically relevant concentrations.
- Assessment of liver slice viability using K+ retention, protein synthesis, and LDH leakage assays at multiple time points.
Main Results:
- Significant inter-individual variability in VPA-induced hepatotoxicity was observed in human liver slices.
- One liver sample exhibited high sensitivity, two showed relative insensitivity, and the rest were intermediate.
- No correlation was found between VPA-induced hepatotoxicity and donor age or sex in this cohort.
Conclusions:
- Human liver slices can serve as a model to study VPA-induced hepatotoxicity.
- In vitro evidence supports differential susceptibility to VPA hepatotoxicity among individuals.
- Further research is needed to explore correlations with VPA metabolism and patient factors.